Sorafenib cardiotoxicity increases mortality after myocardial infarction. [electronic resource]
Producer: 20140714Description: 1700-1712 p. digitalISSN:- 1524-4571
- Animals
- Antineoplastic Agents -- adverse effects
- Apoptosis -- drug effects
- Cats
- Cell Proliferation -- drug effects
- Cells, Cultured
- Disease Models, Animal
- Dose-Response Relationship, Drug
- Heart -- drug effects
- In Vitro Techniques
- Male
- Metoprolol -- pharmacology
- Mice
- Mice, Inbred C57BL
- Myocardial Infarction -- mortality
- Myocytes, Cardiac -- drug effects
- Niacinamide -- adverse effects
- Phenylurea Compounds -- adverse effects
- Proto-Oncogene Proteins c-kit -- drug effects
- Sorafenib
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.